When it comes to treating pediatric cancer a group of academic researchers, oncologists and pathologists believes that a more personal approach isn’t just more humane, it’s the key to survival. For members of the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) this personal touch means using genomic analysis to develop highly targeted therapies to treat each individual tumor.
Read more:
Researchers Look to the Cloud to Develop Personalized Medicine for Kids With Cancer